not only does it help with blood sugar control but also blood pressure, cholesterol and mobility—it can completely change people's lives around." GLP-1 receptor agonists stimulate the body to ...

New research explores the wide world of the positives, and potential drawbacks, of new obesity medications. And each brings a new consideration for physicians.

However, a new class of medications, GLP-1 agonists, originally designed for diabetes and obesity management, shows promise as a revolutionary tool in addiction treatment. GLP-1, or glucagon-like ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

"It is estimated that by 2030, 30 million GLP-1 [receptor agonist] prescriptions will have ... What should eye doctors do in light of the case series and other reports? "Because of the association ...

GLP-1 agonist medications ... Any views, thoughts or opinions in this paid post belong solely to the advertiser and do not represent the views of Lee Enterprises. Any views, thoughts or opinions ...